Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Clinical Pharmacology|May 23, 1998
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measureR F Frye, A Adedoyin, K Mauro, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefonicid in patients with skin and skin structure infectionsK L Heim-Duthoy, G L Peltier, D R Guay, et al.
Annals of Allergy|December 1, 1987
Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiencyG R Matzke, J Yeh, W M Awni, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Disposition of ceftazidime in surgical patients with intra-abdominal infectionK L Heim-Duthoy, M P Bubrick, D M Cocchetto, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1986
The effect of hemodialysis on piperacillin pharmacokineticsK L Heim-Duthoy, C E Halstenson, P A Abraham, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacinS Flor, D R Guay, J A Opsahl, et al.
The Annals of Pharmacotherapy|June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessmentG R Matzke, W L St Peter, T J Comstock, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymesR F Frye, G R Matzke, A Adedoyin, et al.
The Annals of Pharmacotherapy|October 1, 1996
Disposition of foscarnet during peritoneal dialysisA C Alexander, A Akers, G R Matzke, et al.
Pharmacotherapy|March 11, 2000
Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activityG R Matzke, R F Frye, J J Early, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacology|May 23, 1998
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measureR F Frye, A Adedoyin, K Mauro, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefonicid in patients with skin and skin structure infectionsK L Heim-Duthoy, G L Peltier, D R Guay, et al.
Annals of Allergy|December 1, 1987
Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiencyG R Matzke, J Yeh, W M Awni, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Disposition of ceftazidime in surgical patients with intra-abdominal infectionK L Heim-Duthoy, M P Bubrick, D M Cocchetto, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1986
The effect of hemodialysis on piperacillin pharmacokineticsK L Heim-Duthoy, C E Halstenson, P A Abraham, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacinS Flor, D R Guay, J A Opsahl, et al.
The Annals of Pharmacotherapy|June 14, 2000
Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessmentG R Matzke, W L St Peter, T J Comstock, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymesR F Frye, G R Matzke, A Adedoyin, et al.
The Annals of Pharmacotherapy|October 1, 1996
Disposition of foscarnet during peritoneal dialysisA C Alexander, A Akers, G R Matzke, et al.
Pharmacotherapy|March 11, 2000
Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activityG R Matzke, R F Frye, J J Early, et al.
Pageof 13